Selected research
Industry Research
Cell Therapy GMP Manufacturing Platform Industry Research Report 2026
Market perspective
The global Cell Therapy GMP Manufacturing Platform market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Cell Therapy GMP Manufacturing Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Cell Therapy GMP Manufacturing Platform market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Cell Therapy GMP Manufacturing Platform market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Cell Therapy GMP Manufacturing Platform include Cellares, Miltenyi Biotec, Cytiva, Lonza, Adva Biotechnology, BioNTech, 3M, Ori Biotech and Limula, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Cell Therapy GMP Manufacturing Platform market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Cell Therapy GMP Manufacturing Platform.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cell Therapy GMP Manufacturing Platform Market by Company
Cellares
Miltenyi Biotec
Cytiva
Lonza
Adva Biotechnology
BioNTech
3M
Ori Biotech
Limula
Resilience
Cellistic
Catalent
Criver
ElevateBio
Ultragenyx
Cell Therapy GMP Manufacturing Platform Segment by Type
Autologous Cell Therapy GMP Manufacturing Platform
Allogeneic Cell Therapy GMP Manufacturing Platform
Cell Therapy GMP Manufacturing Platform Segment by Application
Clinical Research
Commercial Production
Cell Therapy GMP Manufacturing Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Therapy GMP Manufacturing Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cell Therapy GMP Manufacturing Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Therapy GMP Manufacturing Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Cell Therapy GMP Manufacturing Platform companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Autologous Cell Therapy GMP Manufacturing Platform
- Allogeneic Cell Therapy GMP Manufacturing Platform
Applications
- Clinical Research
- Commercial Production
Companies covered
- Cellares
- Miltenyi Biotec
- Cytiva
- Lonza
- Adva Biotechnology
- BioNTech
- 3M
- Ori Biotech
- Limula
- Resilience
- Cellistic
- Catalent
- Criver
- ElevateBio
- Ultragenyx
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Cell Therapy GMP Manufacturing Platform by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Autologous Cell Therapy GMP Manufacturing Platform
- 2.2.3 Allogeneic Cell Therapy GMP Manufacturing Platform
- 2.3 Cell Therapy GMP Manufacturing Platform by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Clinical Research
- 2.3.3 Commercial Production
- 2.4 Assumptions and Limitations
3 Cell Therapy GMP Manufacturing Platform Breakdown Data by Type
- 3.1 Global Cell Therapy GMP Manufacturing Platform Historic Market Size by Type (2021-2026)
- 3.2 Global Cell Therapy GMP Manufacturing Platform Forecasted Market Size by Type (2027-2032)
4 Cell Therapy GMP Manufacturing Platform Breakdown Data by Application
- 4.1 Global Cell Therapy GMP Manufacturing Platform Historic Market Size by Application (2021-2026)
- 4.2 Global Cell Therapy GMP Manufacturing Platform Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Cell Therapy GMP Manufacturing Platform Market Perspective (2021-2032)
- 5.2 Global Cell Therapy GMP Manufacturing Platform Growth Trends by Region
- 5.2.1 Global Cell Therapy GMP Manufacturing Platform Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Cell Therapy GMP Manufacturing Platform Historic Market Size by Region (2021-2026)
- 5.2.3 Cell Therapy GMP Manufacturing Platform Forecasted Market Size by Region (2027-2032)
- 5.3 Cell Therapy GMP Manufacturing Platform Market Dynamics
- 5.3.1 Cell Therapy GMP Manufacturing Platform Industry Trends
- 5.3.2 Cell Therapy GMP Manufacturing Platform Market Drivers
- 5.3.3 Cell Therapy GMP Manufacturing Platform Market Challenges
- 5.3.4 Cell Therapy GMP Manufacturing Platform Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Cell Therapy GMP Manufacturing Platform Players by Revenue
- 6.1.1 Global Top Cell Therapy GMP Manufacturing Platform Players by Revenue (2021-2026)
- 6.1.2 Global Cell Therapy GMP Manufacturing Platform Revenue Market Share by Players (2021-2026)
- 6.2 Global Cell Therapy GMP Manufacturing Platform Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Cell Therapy GMP Manufacturing Platform Head Office and Area Served
- 6.4 Global Cell Therapy GMP Manufacturing Platform Players, Product Type & Application
- 6.5 Global Cell Therapy GMP Manufacturing Platform Manufacturers Established Date
- 6.6 Global Cell Therapy GMP Manufacturing Platform Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Cell Therapy GMP Manufacturing Platform Market Size (2021-2032)
- 7.2 North America Cell Therapy GMP Manufacturing Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Cell Therapy GMP Manufacturing Platform Market Size by Country (2021-2026)
- 7.4 North America Cell Therapy GMP Manufacturing Platform Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Cell Therapy GMP Manufacturing Platform Market Size (2021-2032)
- 8.2 Europe Cell Therapy GMP Manufacturing Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Cell Therapy GMP Manufacturing Platform Market Size by Country (2021-2026)
- 8.4 Europe Cell Therapy GMP Manufacturing Platform Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Cell Therapy GMP Manufacturing Platform Market Size (2021-2032)
- 9.2 Asia-Pacific Cell Therapy GMP Manufacturing Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Cell Therapy GMP Manufacturing Platform Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Cell Therapy GMP Manufacturing Platform Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Cell Therapy GMP Manufacturing Platform Market Size (2021-2032)
- 10.2 South America Cell Therapy GMP Manufacturing Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Cell Therapy GMP Manufacturing Platform Market Size by Country (2021-2026)
- 10.4 South America Cell Therapy GMP Manufacturing Platform Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Cell Therapy GMP Manufacturing Platform Market Size (2021-2032)
- 11.2 Middle East & Africa Cell Therapy GMP Manufacturing Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Cell Therapy GMP Manufacturing Platform Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Cell Therapy GMP Manufacturing Platform Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Cellares
- 12.1.1 Cellares Company Information
- 12.1.2 Cellares Business Overview
- 12.1.3 Cellares Revenue in Cell Therapy GMP Manufacturing Platform Business (2021-2026)
- 12.1.4 Cellares Cell Therapy GMP Manufacturing Platform Product Portfolio
- 12.1.5 Cellares Recent Developments
- 12.2 Miltenyi Biotec
- 12.2.1 Miltenyi Biotec Company Information
- 12.2.2 Miltenyi Biotec Business Overview
- 12.2.3 Miltenyi Biotec Revenue in Cell Therapy GMP Manufacturing Platform Business (2021-2026)
- 12.2.4 Miltenyi Biotec Cell Therapy GMP Manufacturing Platform Product Portfolio
- 12.2.5 Miltenyi Biotec Recent Developments
- 12.3 Cytiva
- 12.3.1 Cytiva Company Information
- 12.3.2 Cytiva Business Overview
- 12.3.3 Cytiva Revenue in Cell Therapy GMP Manufacturing Platform Business (2021-2026)
- 12.3.4 Cytiva Cell Therapy GMP Manufacturing Platform Product Portfolio
- 12.3.5 Cytiva Recent Developments
- 12.4 Lonza
- 12.4.1 Lonza Company Information
- 12.4.2 Lonza Business Overview
- 12.4.3 Lonza Revenue in Cell Therapy GMP Manufacturing Platform Business (2021-2026)
- 12.4.4 Lonza Cell Therapy GMP Manufacturing Platform Product Portfolio
- 12.4.5 Lonza Recent Developments
- 12.5 Adva Biotechnology
- 12.5.1 Adva Biotechnology Company Information
- 12.5.2 Adva Biotechnology Business Overview
- 12.5.3 Adva Biotechnology Revenue in Cell Therapy GMP Manufacturing Platform Business (2021-2026)
- 12.5.4 Adva Biotechnology Cell Therapy GMP Manufacturing Platform Product Portfolio
- 12.5.5 Adva Biotechnology Recent Developments
- 12.6 BioNTech
- 12.6.1 BioNTech Company Information
- 12.6.2 BioNTech Business Overview
- 12.6.3 BioNTech Revenue in Cell Therapy GMP Manufacturing Platform Business (2021-2026)
- 12.6.4 BioNTech Cell Therapy GMP Manufacturing Platform Product Portfolio
- 12.6.5 BioNTech Recent Developments
- 12.7 3M
- 12.7.1 3M Company Information
- 12.7.2 3M Business Overview
- 12.7.3 3M Revenue in Cell Therapy GMP Manufacturing Platform Business (2021-2026)
- 12.7.4 3M Cell Therapy GMP Manufacturing Platform Product Portfolio
- 12.7.5 3M Recent Developments
- 12.8 Ori Biotech
- 12.8.1 Ori Biotech Company Information
- 12.8.2 Ori Biotech Business Overview
- 12.8.3 Ori Biotech Revenue in Cell Therapy GMP Manufacturing Platform Business (2021-2026)
- 12.8.4 Ori Biotech Cell Therapy GMP Manufacturing Platform Product Portfolio
- 12.8.5 Ori Biotech Recent Developments
- 12.9 Limula
- 12.9.1 Limula Company Information
- 12.9.2 Limula Business Overview
- 12.9.3 Limula Revenue in Cell Therapy GMP Manufacturing Platform Business (2021-2026)
- 12.9.4 Limula Cell Therapy GMP Manufacturing Platform Product Portfolio
- 12.9.5 Limula Recent Developments
- 12.10 Resilience
- 12.10.1 Resilience Company Information
- 12.10.2 Resilience Business Overview
- 12.10.3 Resilience Revenue in Cell Therapy GMP Manufacturing Platform Business (2021-2026)
- 12.10.4 Resilience Cell Therapy GMP Manufacturing Platform Product Portfolio
- 12.10.5 Resilience Recent Developments
- 12.11 Cellistic
- 12.11.1 Cellistic Company Information
- 12.11.2 Cellistic Business Overview
- 12.11.3 Cellistic Revenue in Cell Therapy GMP Manufacturing Platform Business (2021-2026)
- 12.11.4 Cellistic Cell Therapy GMP Manufacturing Platform Product Portfolio
- 12.11.5 Cellistic Recent Developments
- 12.12 Catalent
- 12.12.1 Catalent Company Information
- 12.12.2 Catalent Business Overview
- 12.12.3 Catalent Revenue in Cell Therapy GMP Manufacturing Platform Business (2021-2026)
- 12.12.4 Catalent Cell Therapy GMP Manufacturing Platform Product Portfolio
- 12.12.5 Catalent Recent Developments
- 12.13 Criver
- 12.13.1 Criver Company Information
- 12.13.2 Criver Business Overview
- 12.13.3 Criver Revenue in Cell Therapy GMP Manufacturing Platform Business (2021-2026)
- 12.13.4 Criver Cell Therapy GMP Manufacturing Platform Product Portfolio
- 12.13.5 Criver Recent Developments
- 12.14 ElevateBio
- 12.14.1 ElevateBio Company Information
- 12.14.2 ElevateBio Business Overview
- 12.14.3 ElevateBio Revenue in Cell Therapy GMP Manufacturing Platform Business (2021-2026)
- 12.14.4 ElevateBio Cell Therapy GMP Manufacturing Platform Product Portfolio
- 12.14.5 ElevateBio Recent Developments
- 12.15 Ultragenyx
- 12.15.1 Ultragenyx Company Information
- 12.15.2 Ultragenyx Business Overview
- 12.15.3 Ultragenyx Revenue in Cell Therapy GMP Manufacturing Platform Business (2021-2026)
- 12.15.4 Ultragenyx Cell Therapy GMP Manufacturing Platform Product Portfolio
- 12.15.5 Ultragenyx Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst